BiaCure welcomes Rick Schefelker as VP of Research & Development

BiaCure is excited to welcome Rick Schefelker as Vice President of Research and Development. With over 30 years of experience in medical device innovation and a proven track record of developing groundbreaking technologies, Rick's leadership will drive our mission to cure onychomycosis, a condition affecting over 35 million patients nationwide. 

 

"As Vice President of Research & Development, I am deeply committed to advocating for patients in the fight against onychomycosis, a condition that can be both physically and emotionally debilitating. In this pursuit, I am building a close-knit, collaborative engineering team that thrives on working together to creative innovative, patient-centered solutions. 

 

Our shared mission is to develop effective treatments that not only address this challenging condition but also help restore confidence and improve quality of life for those affected."

  • Rick Schefelker